935777-24-5 Usage
General Description
6-(Trifluoromethyl)pyridazin-3-amine is a chemical compound with the molecular formula C5H4F3N3. It is a derivative of pyridazine and contains a trifluoromethyl group. 6-(Trifluoromethyl)pyridazin-3-amine has potential applications in medical and pharmaceutical research, particularly in the development of new drugs and pharmaceuticals. Its structural features make it a valuable building block for the synthesis of novel organic molecules with potential biological activity. Additionally, its trifluoromethyl group may impart unique chemical and pharmacological properties that could make it useful in the development of new therapeutic agents. Overall, 6-(Trifluoromethyl)pyridazin-3-amine has the potential to be a valuable tool in the field of medicinal chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 935777-24-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,5,7,7 and 7 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 935777-24:
(8*9)+(7*3)+(6*5)+(5*7)+(4*7)+(3*7)+(2*2)+(1*4)=215
215 % 10 = 5
So 935777-24-5 is a valid CAS Registry Number.
935777-24-5Relevant articles and documents
GCN2 INHIBITORS AND USES THEREOF
-
Paragraph 00960; 00961; 00962, (2019/08/12)
The present invention provides compounds, compositions thereof, and methods of using the same.
COMPOUNDS USEFUL AS CSF1 MODULATORS
-
Paragraph 00438; 00439; 00440, (2016/04/26)
This invention relates to novel compounds and to pharmaceutical compositions comprising the novel compounds. More specifically, the invention relates to compounds useful as Colony Stimulating Factor 1 Receptor (cFMS) modulators (e.g. cFMS inhibitors). This invention also relates to processes for preparing the compounds, uses of the compounds in treatment and methods of treatment employing the compounds. Specifically, the invention relates to the use of the compounds for the treatment of cancer and autoimmune diseases.
PIPERIDIN-4-YL-PYRIDAZIN-3-YLAMINE DERIVATIVES AS FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS
-
Page/Page column 16, (2010/11/27)
The present invention relates to compounds that are fast dissociating dopamine 2 receptor antagonists, processes for preparing these compounds, pharmaceutical compositions comprising these compounds as an active ingredient. The compounds find utility as m
